Predictive Biosciences names new CFO, CMO

Predictive Biosciences announced the appointment of two senior executives: Ellen Sheets, M.D., to the newly created position of chief medical officer and Vikram Lamba to the position of CFO.

ProMetic Life Sciences has named Bruce Pritchard as CFO.

XenoPort has named David A. Stamler, M.D., as CMO.

Rexahn Pharmaceuticals announced the appointment of Rick Soni as CBO.

Noven Pharmaceuticals has named Joel Lippman, M.D., as Vice President of Clinical Development & CMO.

Dr. Richard M. Soll has joined WuXi PharmaTec as VP of Medicinal Chemistry.

Synta Pharmaceuticals has chosed Michael P. Bailey as Senior Vice President and Chief Commercial Officer. 
Merck has elected Leslie Brun to its board of directors.

Znomics has named Charles N. Blitzer to board of directors.

Suggested Articles

Levo Therapeutics’ lead program did not beat placebo in a phase 3 study of Prader-Willi syndrome, a genetic disorder that causes insatiable hunger.

Denali is partnering with Biogen on its Parkinson's disease program, netting a $560 million upfront fee and a $465 million investment.

In the first half of 2020, the regenerative medicine sector raised $10.7 billion, more than the total it raised in 2019.